Armistice Capital Master Fund Ltd., 10% Owner at AMAG PHARMACEUTICALS INC. (AMAG), bought 757,032 shares at $8.59 ($6.6M) on 2019-06-25, disclosed to the SEC on 2019-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.59 | 259,016 | $2.2M | 33.5% |
| 2 | $8.59 | 259,016 | $2.2M | 33.5% |
| 3 | $8.85 | 25,000 | $221K | 3.3% |
| 4 | $8.86 | 30,000 | $266K | 4.0% |
| 5 | $9.13 | 120,000 | $1.1M | 16.5% |
| 6 | $9.47 | 20,000 |
| $189K |
| 2.9% |
| 7 | $9.52 | 44,000 | $419K | 6.3% |
| Total | $8.77 avg | 757,032 | $6.6M | 100% |
| Filing → |
| AVTX | BUY | 2022-01-11 | $1.1M | — | Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |